Cas9-Expressing Raji Cell Line

Catalog #
78156
$6,500 *
Size: 2 vials
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

This cell line is a clonal derivative from the Cas9-Expressing Raji Cell Pool (BPS Bioscience, #78071). It was generated by limiting dilution of the original pool and isolation of individual clones, which were screened based on Cas9 expression to obtain a high-expressing cell line. The expressed Cas9 protein includes a C-terminal FLAG tag.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

Synonyms
SpCas9 cell line, CRISPR cell line, Cas9 cell line, B-cell non-Hodgkin lymphoma, NHL
Product Info
Storage and Usage
Citations
Host Cell Line
Human B lymphoblastoid cell line, derived from a patient with Burkitt lymphoma. Suspension cells.
Species
S. pyogenes
Supplied As
Each vial contains ~2 x 106 cells in 1 ml of FBS with 10% DMSO.
UniProt #
Q99ZW2
Mycoplasma Testing

This cell line has been screened using the MycoAlert™ Mycoplasma Detection Kit (Lonza, #LT07-118) to confirm the absence of Mycoplasma contamination. MycoAlert Assay Control Set (Lonza, #LT07-518) was used as a positive control.

Background

Cas9 (Streptococcus pyogenes CRISPR associated protein 9) is an endonuclease enzyme that, when recruited to a specific DNA sequence by the sgRNA (single guide RNA), introduces a double stranded break into the DNA. This double stranded break is repaired in mammalian cells either through Non-Homologous End Joining or Homologous Recombination. Non-Homologous End Joining often results in the deletion or insertion of several base pairs at the cut site, which, when resulting in a frameshift, causes the functional inactivation of the targeted gene. Cas9-expressing Daudi cells can be transduced or electroporated with sgRNA targeting a gene of interest to quickly generate knock-out cell pools or cell lines.